cystic fibrosis | Docwire News

cystic fibrosis

DocWire News EditorsATS 2021 Conference Coverage | May 14, 2021

After one year of treatment with the CFTR modulators elexacaftor-tezacaftor-ivacaftor, patients with cystic fibrosis ...

DocWire News EditorsFuture of Medicine | April 12, 2023

A research team has recently found that a common antifungal drug may be an effective treatment for patients with cystic ...

DocWire News EditorsVideos | April 28, 2023

Greg Duncan, CEO of Celtaxsys discussed cystic fibrosis (CF) and the role of pulmonary exacerbations. Celtaxsys recently ...

DocWire News EditorsVideos | April 28, 2023

Greg Duncan, CEO of Celtaxsys discusses the top line results of the company's Phase 2 EMPIRE-CF trial evaluating oral, ...